Dealert Deals Pet Care Group srl

Giellepi spa Pet Care Group srl

Buyout Italy Drug Retailers (NEC) Family-Owned / Founder(s) / Entrepreneur(s) / Private Individual(s)
Deal summary

Information on the target

Giellepi S.p.A., based in Seregno (Monza Brianza), is a prominent player in the Italian market for the development and distribution of nutraceutical ingredients. Controlled by the Terruzzi family, Giellepi has established itself as a key operator in the sector, focusing on high-quality products that cater to health and wellness. The company has recently expanded its portfolio through a strategic acquisition.

In a significant move, Giellepi has acquired a controlling stake in Pet Care Group S.r.l., the owner of the Integropet brand. Integropet specializes in the online marketing of natural supplements and probiotics aimed at enhancing the well-being of dogs and cats. Following this transaction, Giellepi holds a 41% equity stake in Pet Care Group, positioning itself as the second-largest shareholder after founder Francesco Bellio, who retains a 44.25% stake.

Industry overview in the target’s specific country

The Drug Retailers (NEC) industry in Italy has been experiencing notable growth, driven by increasing consumer awareness regarding health and wellness. This sector encompasses a variety of businesses that provide pharmaceutical products, health supplements, and other related goods. The rise in pet ownership and the growing trend of pet humanization have further fueled demand for specialized products, including nutraceuticals for pets.

In recent years, the Italian market has seen a shift towards online retailing, particularly in the drug and health supplement segments. E-commerce platforms have become essential for reaching a broader customer base, allowing companies like Integropet to thrive. This trend is supported by advancements in technology and changing consumer behaviors, which favor the convenience of online shopping.

Moreover, regulatory frameworks in Italy have been evolving to accommodate the growing nutraceutical sector, ensuring that products meet safety and efficacy standards. This regulatory support is crucial for companies operating in the Drug Retailers (NEC) industry, as it enhances consumer trust and encourages innovation in product offerings. The competitive landscape is characterized by both established players and new entrants, all vying for market share in this dynamic environment.

The rationale behind the deal The acquisition of Pet Care Group by Giellepi is a strategic move aimed at diversifying its product offerings and tapping into the burgeoning market for pet he…

This is a public preview. The full deal page — disclosed financials, full description, advisers, comparable set — is available with a free account.
Create free account
View primary source ↗